Wenzhou Yu
Overview
Explore the profile of Wenzhou Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
526
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ren M, Li K, Li Y, Fan C, Xu Y, Zhang L, et al.
China CDC Wkly
. 2024 Aug;
6(33):834-840.
PMID: 39211439
Introduction: The type b (Hib) conjugate vaccine is widely administered in China. Methods: We extracted data on Hib vaccine doses administered and adverse events following immunization (AEFI) reported between 2010...
2.
Chen J, Zhang Z, Pan W, Song Y, Zheng L, Li L, et al.
China CDC Wkly
. 2024 Jun;
6(19):413-417.
PMID: 38854753
What Is Already Known On This Topic?: There is a lack of comprehensive data on the coverage of the human papillomavirus (HPV) vaccine in China. The limited published literature hampers...
3.
Li L, Liang H, Song Y, Zhang Z, An J, Li N, et al.
China CDC Wkly
. 2024 Jun;
6(19):418-423.
PMID: 38854752
What Is Already Known On This Topic?: In China, there is limited data available on the use and coverage of the non-program, combined diphtheria, tetanus toxoid, acellular pertussis adsorbed, inactivated...
4.
Song Q, Li Y, Cao L, Hao L, Wen N, Wang F, et al.
China CDC Wkly
. 2024 May;
6(16):339-343.
PMID: 38736466
What Is Already Known About This Topic?: The incidences of vaccine-preventable diseases (VPDs) included in the Expanded Program on Immunization in China have decreased significantly in recent decades. What Is...
5.
Liu L, Zhang Z, Zhang X, Xu C, Song Y, Li L, et al.
China CDC Wkly
. 2023 May;
5(17):379-384.
PMID: 37197448
What Is Already Known On This Topic?: Limited data exist regarding the coverage of the 13-valent pneumococcal conjugate vaccine (PCV13) in China. A lack of official statistics, coupled with an...
6.
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease
Wang J, Song Y, Xie W, Zhao J, Wang Y, Yu W
iScience
. 2023 May;
26(5):106577.
PMID: 37192972
Ischemic heart disease (IHD) remains the leading cause of death and disability worldwide and leads to myocardial necrosis and negative myocardial remodeling, ultimately leading to heart failure. Current treatments include...
7.
Cao M, Zhao J, Huang C, Wang X, Ye L, Han X, et al.
Front Public Health
. 2023 May;
11:1090609.
PMID: 37124767
Introduction: Vaccine hesitancy may increase infectious disease burden and impede disease control efforts, while few studies have measured such a phenomenon with a standardized tool in China. This study aimed...
8.
Yang F, Yu W, Wen J, Jiang W, Emmanuel N
J Environ Manage
. 2023 Apr;
338:117829.
PMID: 37023602
With the strengthened awareness of environmental protection and the growing interests of wastes recycling, silicon recovery from polycrystalline silicon kerf loss (PSKL) has drawn extensive attentions all over the world....
9.
Wang W, Zhang X, Zhang Z, Song Y, Tang L, Wu J, et al.
Zhonghua Yu Fang Yi Xue Za Zhi
. 2022 Dec;
56(12):1821-1827.
PMID: 36536572
To analyze the trust in vaccination and its influencing factors in parents of children aged 0-6 years. In June 2021, a cross-sectional survey was conducted to collect the basic information...
10.
Zhang Z, Shi J, Zhang X, Guo X, Yu W
Vaccine
. 2022 Nov;
41(1):130-135.
PMID: 36411136
Objective: To assess knowledge about HPV and HPV vaccine, willingness to have their daughters receive HPV vaccine, and factors associated with knowledge and willingness among parents of females 9 to...